CN Patent

CN112638906B — 一种阿片样物质受体(mor)激动剂的结晶形式及制备方法

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2022-05-27 · 4y expired

What this patent protects

一种阿片样物质受体(MOR)激动剂的结晶形式及制备方法。具体地，提供(1S,4S)‑4‑乙氧基‑N‑(2‑((R)‑9‑(吡啶‑2‑基)‑6‑氧杂螺[4.5]癸‑9‑基)乙基)‑1,2,3,4‑四氢萘‑1‑胺富马酸盐(式(I)所示化合物)的II晶型及其制备方法。式(I)化合物的II晶型具备良好的晶型稳定性，可更好地用于临床治疗。

USPTO Abstract

一种阿片样物质受体(MOR)激动剂的结晶形式及制备方法。具体地，提供(1S,4S)‑4‑乙氧基‑N‑(2‑((R)‑9‑(吡啶‑2‑基)‑6‑氧杂螺[4.5]癸‑9‑基)乙基)‑1,2,3,4‑四氢萘‑1‑胺富马酸盐(式(I)所示化合物)的II晶型及其制备方法。式(I)化合物的II晶型具备良好的晶型稳定性，可更好地用于临床治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN112638906B
Jurisdiction
CN
Classification
—
Expires
2022-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.